Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yaron Rotman

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
Hepatology (Baltimore, Md.)|September 8, 2011
Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C patientsBirgit Edlich, Golo Ahlenstiel, Aintzane Zabaleta Azpiroz, et al.
Hepatology (Baltimore, Md.)|April 5, 2014
Ribavirin improves the IFN-γ response of natural killer cells to IFN-based therapy of hepatitis C virus infectionJens M Werner, Elisavet Serti, Xenia Chepa-Lotrea, et al.
Alimentary Pharmacology & Therapeutics|May 28, 2021
Durable virological response and functional cure of chronic hepatitis D after long-term peginterferon therapyJulian Hercun, Grace E Kim, Ben L Da, et al.
Gastroenterology|July 12, 2011
Early changes in natural killer cell function indicate virologic response to interferon therapy for hepatitis CGolo Ahlenstiel, Birgit Edlich, Leah J Hogdal, et al.
Nature Communications|November 18, 2024
G<sub>12/13</sub>-mediated signaling stimulates hepatic glucose production and has a major impact on whole body glucose homeostasisSrinivas Pittala, Dhanush Haspula, Yinghong Cui, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|April 12, 2018
Development of a Validated Interferon Score Using NanoString TechnologyHanna Kim, Adriana A de Jesus, Stephen R Brooks, et al.
Hepatology (Baltimore, Md.)|August 8, 2014
Understanding early serum hepatitis D virus and hepatitis B surface antigen kinetics during pegylated interferon-alpha therapy via mathematical modelingJeremie Guedj, Yaron Rotman, Scott J Cotler, et al.
Journal of Clinical Gastroenterology|February 19, 2008
The 13C-caffeine breath test detects significant fibrosis in patients with nonalcoholic steatohepatitisHemda Schmilovitz-Weiss, Yaron Niv, Orit Pappo, et al.
Gastroenterology|September 15, 2009
Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent mannerGolo Ahlenstiel, Rachel H Titerence, Christopher Koh, et al.
Hepatology Communications|February 16, 2019
Development of Hepatic Steatosis After Chemotherapy for Non-Hodgkin LymphomaGil Ben-Yakov, Hawwa Alao, John P Haydek, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Hepatology (Baltimore, Md.)|September 8, 2011
Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C patientsBirgit Edlich, Golo Ahlenstiel, Aintzane Zabaleta Azpiroz, et al.
Hepatology (Baltimore, Md.)|April 5, 2014
Ribavirin improves the IFN-γ response of natural killer cells to IFN-based therapy of hepatitis C virus infectionJens M Werner, Elisavet Serti, Xenia Chepa-Lotrea, et al.
Alimentary Pharmacology & Therapeutics|May 28, 2021
Durable virological response and functional cure of chronic hepatitis D after long-term peginterferon therapyJulian Hercun, Grace E Kim, Ben L Da, et al.
Gastroenterology|July 12, 2011
Early changes in natural killer cell function indicate virologic response to interferon therapy for hepatitis CGolo Ahlenstiel, Birgit Edlich, Leah J Hogdal, et al.
Nature Communications|November 18, 2024
G<sub>12/13</sub>-mediated signaling stimulates hepatic glucose production and has a major impact on whole body glucose homeostasisSrinivas Pittala, Dhanush Haspula, Yinghong Cui, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|April 12, 2018
Development of a Validated Interferon Score Using NanoString TechnologyHanna Kim, Adriana A de Jesus, Stephen R Brooks, et al.
Hepatology (Baltimore, Md.)|August 8, 2014
Understanding early serum hepatitis D virus and hepatitis B surface antigen kinetics during pegylated interferon-alpha therapy via mathematical modelingJeremie Guedj, Yaron Rotman, Scott J Cotler, et al.
Journal of Clinical Gastroenterology|February 19, 2008
The 13C-caffeine breath test detects significant fibrosis in patients with nonalcoholic steatohepatitisHemda Schmilovitz-Weiss, Yaron Niv, Orit Pappo, et al.
Gastroenterology|September 15, 2009
Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent mannerGolo Ahlenstiel, Rachel H Titerence, Christopher Koh, et al.
Hepatology Communications|February 16, 2019
Development of Hepatic Steatosis After Chemotherapy for Non-Hodgkin LymphomaGil Ben-Yakov, Hawwa Alao, John P Haydek, et al.
Pageof 8